ENTRY       D04300                      Drug
NAME        Ganaxolone (USAN/INN);
            Ztalmy (TN)
PRODUCT     ZTALMY (Marinus Pharmaceuticals)
FORMULA     C22H36O2
EXACT_MASS  332.2715
MOL_WEIGHT  332.52
CLASS       Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      ATC code: N03AX27
            Product: D04300<US>
EFFICACY    Antiepileptic, Antimigraine
  DISEASE   Seizures associated with cyclin-dependent kinase-like 5 deficiency disorder [DS:H01819]
COMMENT     Allopregnanolone [CPD:C15484] analog
            Treatment of epilepsy and migraine
TARGET      GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]
  PATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction
            hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP2B6 [HSA:1555], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX27 Ganaxolone
                  D04300  Ganaxolone (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Gamma-aminobutyric Acid (GABA) Augmenting Agents
               GABA Agents, Other
                Ganaxolone
                 D04300  Ganaxolone (USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               D04300  Ganaxolone
              DG01639  CYP2C19 substrate
               D04300  Ganaxolone
              DG01644  CYP2D6 substrate
               D04300  Ganaxolone
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04300  Ganaxolone
              DG02925  CYP3A5 substrate
               D04300  Ganaxolone
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               GABA (ionotropic)
                GABR
                 D04300  Ganaxolone (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04300
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04300
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04300
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04300
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D04300
DBLINKS     CAS: 38398-32-2
            PubChem: 47206230
            ChEBI: 177658
            LigandBox: D04300
            NIKKAJI: J805.191G
ATOM        24
            1   C1x C    38.1743  -26.7423
            2   C1z C    38.1743  -28.1094
            3   C1x C    39.3363  -28.7930
            4   C1y C    40.5668  -28.1094
            5   C1z C    40.5668  -26.7423
            6   C1x C    39.3363  -26.0587
            7   C1x C    41.7288  -28.7930
            8   C1x C    42.8909  -28.1094
            9   C1y C    42.8909  -26.7423
            10  C1y C    41.7288  -26.0587
            11  C1y C    44.1213  -26.0587
            12  C1z C    44.1213  -24.6916
            13  C1x C    42.8909  -24.0080
            14  C1x C    41.7288  -24.6916
            15  C1a C    40.5668  -25.3751
            16  C1a C    44.1213  -23.3244
            17  C1a C    36.8071  -28.1094
            18  O1a O    37.8325  -29.4082
            19  C1x C    46.5138  -26.0587
            20  C1x C    46.5138  -24.6916
            21  C1y C    45.2834  -24.0080
            22  C5a C    45.2666  -22.6410
            23  C1a C    44.0870  -21.9792
            24  O5a O    46.4544  -21.9354
BOND        27
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   12  13 1
            14   13  14 1
            15   10  14 1
            16    5  15 1 #Up
            17   12  16 1 #Up
            18    2  17 1 #Up
            19    2  18 1 #Down
            20   11  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1 #Up
            24   22  23 1
            25   22  24 2
            26   21  12 1
            27   12  11 1
///
